Gsa Capital Partners LLP Mannkind Corp Transaction History
Gsa Capital Partners LLP
- $1.35 Billion
- Q4 2024
A detailed history of Gsa Capital Partners LLP transactions in Mannkind Corp stock. As of the latest transaction made, Gsa Capital Partners LLP holds 304,581 shares of MNKD stock, worth $1.72 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
304,581
Previous 15,342
1885.28%
Holding current value
$1.72 Million
Previous $97,000
1918.56%
% of portfolio
0.15%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding MNKD
# of Institutions
260Shares Held
161MCall Options Held
1.97MPut Options Held
943K-
Black Rock Inc. New York, NY22.6MShares$127 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$90.7 Million0.0% of portfolio
-
State Street Corp Boston, MA9.95MShares$56.2 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$49.4 Million0.82% of portfolio
-
Nitorum Capital, L.P. New York, NY8.75MShares$49.4 Million8.23% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.45B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...